OSCR Stock Overview
Operates as a health insurance in the United States. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 4/6 |
Past Performance | 2/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Narratives bring a range of perspectives from our community.
Oscar Health, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$14.72 |
52 Week High | US$23.79 |
52 Week Low | US$8.44 |
Beta | 1.7 |
1 Month Change | -5.70% |
3 Month Change | -19.47% |
1 Year Change | 51.91% |
3 Year Change | 117.43% |
5 Year Change | n/a |
Change since IPO | -57.70% |
Recent News & Updates
Recent updates
Investors Give Oscar Health, Inc. (NYSE:OSCR) Shares A 25% Hiding
Dec 20Not Many Are Piling Into Oscar Health, Inc. (NYSE:OSCR) Stock Yet As It Plummets 27%
Oct 29Not Many Are Piling Into Oscar Health, Inc. (NYSE:OSCR) Just Yet
Sep 13Oscar Health: At Nearly 4x Book Value Investors Should Wait For A Pullback
Sep 03Oscar Health: Achieves Profitability In Q1 2024, But Uncertainties Remain
Jul 02Results: Oscar Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
May 11Investors Still Aren't Entirely Convinced By Oscar Health, Inc.'s (NYSE:OSCR) Revenues Despite 30% Price Jump
May 03Oscar Health: Strong Industry Catalyst With Margin Expansion Potential
Apr 13This Analyst Just Made An Upgrade To Their Oscar Health, Inc. (NYSE:OSCR) Earnings Forecasts
Feb 12Oscar Health, Inc. (NYSE:OSCR) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
Feb 10Oscar Health: Flexible Business Model Is Paying Off
Jan 30Further Upside For Oscar Health, Inc. (NYSE:OSCR) Shares Could Introduce Price Risks After 37% Bounce
Jan 19Oscar Health, Inc. (NYSE:OSCR) Soars 49% But It's A Story Of Risk Vs Reward
Nov 21Oscar Health: Q3 Earnings Suggest Growth Can Continue Into 2024
Nov 15Oscar Health: Decreasing Memberships Is Worrying
Sep 22Oscar Health Shares Quadrupled, But They Are Still Cheap
Jul 03Oscar Health: High Growth And Improving Profitability Make It A Buy
Jun 15Oscar Health Insurance GAAP EPS of -$1.05 beats by $0.03, revenue of $995M misses by $415M
Feb 09Oscar Health: Wait For Concrete Evidence The Business Can Turn Profitable
Jan 18Oscar Health Is Back On Track
Nov 11Oscar Health: Improving Risk/Reward Profile To Watch
Oct 03Florida health insurer terminating agreement with Oscar Health
Aug 30Shareholder Returns
OSCR | US Insurance | US Market | |
---|---|---|---|
7D | 8.4% | -0.7% | -0.2% |
1Y | 51.9% | 23.2% | 25.8% |
Return vs Industry: OSCR exceeded the US Insurance industry which returned 23.2% over the past year.
Return vs Market: OSCR exceeded the US Market which returned 25.8% over the past year.
Price Volatility
OSCR volatility | |
---|---|
OSCR Average Weekly Movement | 11.9% |
Insurance Industry Average Movement | 4.2% |
Market Average Movement | 6.4% |
10% most volatile stocks in US Market | 18.6% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: OSCR's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: OSCR's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2012 | 2,400 | Mark Bertolini | www.hioscar.com |
Oscar Health, Inc. operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Oscar Health, Inc. Fundamentals Summary
OSCR fundamental statistics | |
---|---|
Market cap | US$3.54b |
Earnings (TTM) | US$28.95m |
Revenue (TTM) | US$8.22b |
125.6x
P/E Ratio0.4x
P/S RatioIs OSCR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
OSCR income statement (TTM) | |
---|---|
Revenue | US$8.22b |
Cost of Revenue | US$6.47b |
Gross Profit | US$1.74b |
Other Expenses | US$1.71b |
Earnings | US$28.95m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.12 |
Gross Margin | 21.21% |
Net Profit Margin | 0.35% |
Debt/Equity Ratio | 25.7% |
How did OSCR perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/06 22:27 |
End of Day Share Price | 2025/01/06 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Oscar Health, Inc. is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Hua Ha | Baird |
Kevin Fischbeck | BofA Global Research |
Adam Ron | BofA Global Research |